RE:Organigram
I've exited about 95% of my position and taken a hefty loss with inmed. They haven't been able to get granted patents for the last 4 years and seems to be hitting more delays than expected on all fronts. The most concerning is they can't seem to drum up interest from investors based on volume action, but likely a result of no granted patents, low cash, reverse split, vague answers at business updates, etc. Unfortunately not looking good. Wishing the remaining investors best of luck